Monte Rosa Therapeutics, Inc.
GLUE
$18.15
-$0.53-2.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 76.67% | -3.62% | 34.64% | -10.88% | -12.38% |
| Total Receivables | -60.27% | 133.64% | 109.49% | 68.32% | 713.87% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 49.92% | -19.90% | -13.95% | 35.49% | -6.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 72.32% | -2.15% | 34.18% | -9.88% | -11.96% |
|
|
|||||
| Total Current Assets | 72.32% | -2.15% | 34.18% | -9.88% | -11.96% |
| Net Property, Plant & Equipment | 5.42% | -4.35% | -3.77% | -1.57% | -1.27% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 13.27% | -4.83% | -0.63% | 1.41% | 6.87% |
| Total Assets | 64.14% | -2.43% | 27.88% | -8.55% | -10.38% |
|
|
|||||
| Total Accounts Payable | 122.54% | -75.53% | 159.97% | -13.99% | -62.31% |
| Total Accrued Expenses | -13.65% | 54.57% | 32.59% | 3.28% | -23.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.96% | 3.68% | 3.59% | 5.92% | 4.07% |
| Total Finance Division Other Current Liabilities | 18.67% | 17.79% | 32.74% | -46.15% | -69.32% |
| Total Other Current Liabilities | 18.67% | 17.79% | 32.74% | -46.15% | -69.32% |
| Total Current Liabilities | 10.63% | 4.51% | 46.81% | -29.32% | -62.27% |
|
|
|||||
| Total Current Liabilities | 10.63% | 4.51% | 46.81% | -29.32% | -62.27% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.61% | -3.15% | -3.00% | -2.53% | -2.57% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -6.61% | -0.03% | 824.42% | -39.41% | 4.91% |
| Total Liabilities | -0.51% | 0.75% | 133.87% | -22.48% | -45.30% |
|
|
|||||
| Common Stock & APIC | 46.81% | 4.99% | 0.70% | 0.78% | 0.80% |
| Retained Earnings | -9.33% | -10.70% | -6.70% | -3.14% | 10.69% |
| Treasury Stock & Other | -24.01% | -17.86% | 3.74% | -1.32% | 0.80% |
| Total Common Equity | 123.94% | -5.20% | -8.30% | -2.57% | 23.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 123.94% | -5.20% | -8.30% | -2.57% | 23.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 123.94% | -5.20% | -8.30% | -2.57% | 23.43% |
|
|
|||||